Ovid Therapeutics Inc.
SEC Filing List
OVID CIK: 0001636651
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | Ovid Therapeutics Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/27/2026 | |
| ARS | Annual report to security holders | Ovid Therapeutics Inc. | Workiva Inc. Wdesk FA01 /fa | 04/27/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Ovid Therapeutics Inc. | Workiva Inc. Wdesk FA01 /fa | 04/27/2026 | |
| DEF 14A | Definitive proxy statements | Ovid Therapeutics Inc. | Workiva Inc. Wdesk FA01 /fa | 04/27/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 04/24/2026 | ||
| S-3 | Registration statement for specified tra... | Ovid Therapeutics Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/21/2026 | |
| 8-K | Current report filing | Ovid Therapeutics Inc. | Workiva Inc. Wdesk FA01 /fa | 04/20/2026 | |
| 4 | Statement of changes in beneficial owner... | Friedman Bart | Ovid Therapeutics Inc. | 04/09/2026 | |
| 4 | Statement of changes in beneficial owner... | Fitzgerald Kevin Joseph | Ovid Therapeutics Inc. | 04/09/2026 | |
| 4 | Statement of changes in beneficial owner... | Papadopoulos Stelios | Ovid Therapeutics Inc. | 04/09/2026 | |
| No record found. | |||||
| Load More | |||||
